Longview Acquisition Corp. II (Nasdaq: LGV) is a blank-check company sponsored by Glenview Capital Management, the healthcare-focused investment firm led by Larry Robbins. The SPAC completed its initial public offering in 2021 with a stated focus on identifying a target in the healthcare and life sciences sector. As of its Form 10-Q filed November 14, 2022, with accession number 0001410578-22-003239, the company remained in its business combination search phase with no definitive agreement announced. Glenview previously completed a SPAC transaction through the original Longview Acquisition Corp., making LGV the firm's second vehicle in the space. Sign up at SpacDesk for full filing history, timeline data, and sponsor analytics on LGV and hundreds of other active and closed SPACs.